LS7-25698-23623
2 vaccinations
1 coded response
19 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 191 / PA
- Registered
- 2022-01-30
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Registered dependents
N2A-11849-79394
Child or adolescent in my care · Female · 2022-01-30
Timeline
-
2022-01-26
Dose 1 — Moderna
-
2022-01-30
Registered in v-safe
-
2022-01-30
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pruritus — Feeling: Good · Site: SwellingFree text: Day 2 and 3 I experienced a lot of itching at the injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-01-31
- 2022-02-01
- 2022-02-02
- 2022-02-09
- 2022-02-16
-
2022-02-21
Dose 2 — Moderna
- 2022-02-24
- 2022-02-25
- 2022-02-26
- 2022-02-27
- 2022-03-02
- 2022-03-07
- 2022-03-14
- 2022-03-21
- 2022-03-28
- 2022-04-04
- 2022-05-23
- 2022-08-24
- 2023-02-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-26 | Moderna | No |
| 2 | 2022-02-21 | Moderna | No |
Free text
Release 11 — days 1–6 daily, dose 1
Systemic reaction (other): Day 2 and 3 I experienced a lot of itching at the injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site pruritus | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release